Feb 11 2026HEALTH
Moderna’s New Flu Shot Hits a Roadblock
The U. S. Food and Drug Administration has decided not to review Moderna’s mRNA flu vaccine, even though the company spent years and millions of dollars on testing. The decision came after the agency’s chief vaccine regulator, Dr. Vinay Prasad, raised a concern. He said the trial used a compar
reading time less than a minute
